Katana VentraIP

Neurodegenerative disease

A neurodegenerative disease is caused by the progressive loss of structure or function of neurons, in the process known as neurodegeneration. Such neuronal damage may ultimately involve cell death. Neurodegenerative diseases include amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, Alzheimer's disease, Huntington's disease, multiple system atrophy, tauopathies, and prion diseases. Neurodegeneration can be found in the brain at many different levels of neuronal circuitry, ranging from molecular to systemic. Because there is no known way to reverse the progressive degeneration of neurons, these diseases are considered to be incurable; however research has shown that the two major contributing factors to neurodegeneration are oxidative stress and inflammation.[2][3][4][5] Biomedical research has revealed many similarities between these diseases at the subcellular level, including atypical protein assemblies (like proteinopathy) and induced cell death.[6][7] These similarities suggest that therapeutic advances against one neurodegenerative disease might ameliorate other diseases as well.

For the medical journal, see Experimental Neurology.

Neurodegenerative disease

Within neurodegenerative diseases, it is estimated that 55 million people worldwide had dementia in 2019, and that by 2050 this figure will increase to 139 million people.[8]

: can aggregate to form insoluble fibrils in pathological conditions characterized by Lewy bodies, such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Alpha-synuclein is the primary structural component of Lewy body fibrils. In addition, an alpha-synuclein fragment, known as the non-Abeta component (NAC), is found in amyloid plaques in Alzheimer's disease.

alpha-synuclein

: hyperphosphorylated tau protein is the main component of neurofibrillary tangles in Alzheimer's disease; tau fibrils are the main component of Pick bodies found in behavioral variant frontotemporal dementia.

tau

: the major component of amyloid plaques in Alzheimer's disease.

amyloid beta

Amyloid

JUNQ and IPOD

Neurodegeneration with brain iron accumulation

Prevention of dementia

Min YG, Choi SJ, Hong YH, Kim SM, Shin JY, Sung JJ. Dissociated leg muscle atrophy in amyotrophic lateral sclerosis/motor neuron disease: the 'split-leg' sign. Sci Rep. 2020 Sep 24;10(1):15661. :10.1038/s41598-020-72887-7. PMID 32973334; PMCID: PMC7518279.

doi

K. A. Irvine, W. F. Blakemore, Remyelination protects axons from demyelination-associated axon degeneration, Brain, Volume 131, Issue 6, June 2008, Pages 1464–1477, :10.1093/brain/awn080

doi